Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke

Background: Leukoaraiosis (LA) is closely associated with aging, a major determinant of clinical outcome after ischemic stroke. In this study we sought to identify whether LA, independent of advancing age, affects outcome after acute ischemic stroke. Methods: LA volume was quantified in 240 patients with ischemic stroke and MRI within 24 hours of symptom onset. We explored the relationship between LA volume at admission and clinical outcome at 6 months, as assessed by the modified Rankin Scale (mRS). An ordinal logistic regression model was developed to analyze the independent effect of LA volume on clinical outcome. Results: Bivariate analyses showed a significant correlation between LA volume and mRS at 6 months (r = 0.19, p = 0.003). Mean mRS was 1.7 ± 1.8 among those in the lowest (≤1.2 mL) and 2.5 ± 1.9 in the highest (>9.9 mL) quartiles of LA volume (p = 0.01). The unfavorable prognostic effect of LA volume on clinical outcome was retained in the multivariable model (p = 0.002), which included age, gender, stroke risk factors (hypertension, diabetes mellitus, atrial fibrillation), previous history of brain infarction, admission plasma glucose level, admission NIH Stroke Scale score, IV rtPA treatment, and acute infarct volume on MRI as covariates. Conclusions: The volume of leukoaraiosis is a predictor of clinical outcome after ischemic stroke and this relationship persists after adjustment for important prognostic factors including age, initial stroke severity, and infarct volume.

[1]  G. Kempen,et al.  Psychological attributes and changes in disability among low-functioning older persons: does attrition affect the outcomes? , 2002, Journal of clinical epidemiology.

[2]  R. Sacco,et al.  Mortality and causes of death after first ischemic stroke , 2001, Neurology.

[3]  Evan Fletcher,et al.  White Matter Changes Compromise Prefrontal Cortex Function in Healthy Elderly Individuals , 2006, Journal of Cognitive Neuroscience.

[4]  M. Dombovy,et al.  Rehabilitation for stroke: a review. , 1986, Stroke.

[5]  D. Heistad,et al.  Impaired dilatation of cerebral arterioles in chronic hypertension. , 1990, Blood vessels.

[6]  J. Bogousslavsky,et al.  Arterial territories of the human brain , 1998, Neurology.

[7]  A. Buchan.  Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial , 2005 .

[8]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[9]  Abciximab Emergent Stroke Treatment Trial Investigators,et al.  Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of a Randomized Phase 2 Trial , 2005, Stroke.

[10]  Thomas Benner,et al.  A Computerized Algorithm for Etiologic Classification of Ischemic Stroke: The Causative Classification of Stroke System , 2007, Stroke.

[11]  A. Buchan,et al.  Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke , 2007, Neurology.

[12]  P. Scheltens,et al.  Age, Hypertension, and Lacunar Stroke Are the Major Determinants of the Severity of Age-Related White Matter Changes , 2006, Cerebrovascular Diseases.

[13]  F. Barkhof,et al.  CT and MRI Rating of White Matter Lesions , 2002, Cerebrovascular Diseases.

[14]  S. Kumita,et al.  Loss of interhemispheric connectivity in patients with lacunar infarction reflected by diffusion-weighted MR imaging and single-photon emission CT. , 1999, AJNR. American journal of neuroradiology.

[15]  T. Olsen,et al.  Leukoaraiosis in stroke patients. The Copenhagen Stroke Study. , 1995, Stroke.

[16]  V. Hachinski,et al.  Prognostic Importance of Leukoaraiosis in Patients With Symptomatic Internal Carotid Artery Stenosis , 2002, Stroke.

[17]  G. Fink,et al.  Cortical connectivity after subcortical stroke assessed with functional magnetic resonance imaging , 2008, Annals of neurology.

[18]  Fisher Cm,et al.  Binswanger's encephalopathy: a review , 1989 .

[19]  R. Baggott.  DISEASE , 1947, Social Policy & Administration.

[20]  C. Fisher.  Binswanger's encephalopathy: a review , 2004, Journal of Neurology.

[21]  Liam Glynn,et al.  Selection bias resulting from the requirement for prior consent in observational research: a community cohort of people with ischaemic heart disease , 2007, Heart.

[22]  D. Kaloupek,et al.  Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. , 1986, Stroke.

[23]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[24]  Carl D Langefeld,et al.  Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. , 2004, Radiology.

[25]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[26]  M. O’Sullivan,et al.  Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis , 2002, Neurology.

[27]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[28]  S. Pocock,et al.  Can We Improve the Statistical Analysis of Stroke Trials?: Statistical Reanalysis of Functional Outcomes in Stroke Trials , 2007, Stroke.

[29]  A. Ziegler,et al.  Age and National Institutes of Health Stroke Scale Score Within 6 Hours After Onset Are Accurate Predictors of Outcome After Cerebral Ischemia: Development and External Validation of Prognostic Models , 2003, Stroke.

[30]  A Gregory Sorensen,et al.  Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke , 2008, Stroke.

[31]  A. Hofman,et al.  Periventricular cerebral white matter lesions predict rate of cognitive decline , 2002, Annals of neurology.

[32]  P. Dorman,et al.  Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies , 2008, BMJ : British Medical Journal.

[33]  Eric E. Smith,et al.  Validation of Intracranial Area as a Surrogate Measure of Intracranial Volume When Using Clinical MRI , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[34]  A. Sorensen,et al.  Conversion of Ischemic Brain Tissue Into Infarction Increases With Age , 2005, Stroke.

[35]  W R Clarke,et al.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.

[36]  Susan Robinson,et al.  German , 2006 .

[37]  D. Leys,et al.  Leukoaraiosis More Than Dementia Is a Predictor of Stroke Recurrence , 2003, Stroke.

[38]  Eric E. Smith,et al.  Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.

[39]  Norman J Beauchamp,et al.  White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.

[40]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[41]  H. Yamanouchi,et al.  Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of binswanger type , 1989, Journal of Neurology.

[42]  S. Corr.  Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials , 2007 .

[43]  A. Sorensen,et al.  Interexaminer Difference in Infarct Volume Measurements on MRI: A Source of Variance in Stroke Research , 2008, Stroke.

[44]  M. Wasay,et al.  Cerebral White Matter Changes (Leukoaraiosis), Stroke, and Gait Disturbance , 1997, Journal of the American Geriatrics Society.

[45]  J. Saver,et al.  Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. , 2004, Archives of neurology.